As the demand for GLP-1 weight loss medications such as Ozempic, Wegovy, and Zepbound continues to skyrocket, a new survey reveals that access to those medications has become a critical factor in job retention and acquisition.
According to new data from 9amHealth — which provides specialized care for weight management, diabetes, and heart health — 54% of Americans are using or want to use a GLP-1 medication. That’s a 6% increase from last year. Compared to last year’s findings, even more employees said that GLP-1 coverage was important for taking or staying at a job (73%, up from 67%). Employer-sponsored coverage of these medications has more than doubled, too — rising from 30% to 63%.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
